The last time we saw today's setup, one group of stocks more than doubled in four years and left U.S. stocks in the dust… It has nothing to do with China. And it might surprise you… European stocks are now dirt-cheap compared with their U.S. counterparts. Based on history, that means we could see an incredible scenario… European stocks could significantly....More>>>
The incredible year for Steve Sjuggerud's True Wealth China Opportunities subscribers continues… Regular DailyWealth readers know Steve made a bold call last summer. In short, despite years of dismal performance – and widespread fear of economic collapse – Steve said Chinese stocks were a "buy" again. At the time, Steve noted that Chinese stocks....More>>>
There is an age-old saying in investing in the stock market that earnings drive stock prices. That may be true on the fundamental side of investing theory, but certain mechanics in the market actually drive the markets more than fundamental theory. Quite simply, more money from buyers (inflows) than there are sellers (outflows) will drive the stock market higher. The other side of the coin is that....More>>>
Mid-cap stocks tend to have more solid financial underpinnings than small caps, but lack the size and scale of large caps. They can present an odd, though sometimes intriguing, mix of growth and stability.
That’s certainly the case with surprisingly diversified biotech company Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), out-of-favor outlet mall owner Tanger Factory Outlet Centers,....More>>>
According to a recent report (“Internet of Medical Things Enabling Hospitals of the Future”) from Frost & Sullivan, the Internet of Medical Things (IoMT) is helping to drive the home healthcare industry into new innovations that are clustered around wearables and eSkin devices – the type of devices that small cap Biotricity Inc (OTCQB: BTCY) is developing. To begin with, the Internet....More>>>
China Biologic Products Holdings Inc (NASDAQ:CBPO) has earned a consensus rating of “Hold” from the six brokerages that are currently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1 year price objective among brokerages that have issued ratings on the stock....More>>>
There was good news and bad news for Tesla Inc. (TSLA) on Tuesday, which closed down $3.52, or 1.21%, at $287.69, but was climbing after hours.
The bad news is that Tesla is halting the production of its Model 3 sedan for four to five days in an unexpected move aimed at improving output. The good news is that China is easing its auto regulations and making it easier for foreign....More>>>
European stocks closed lower Monday, dragged down in part by falls for consumer products heavyweight Reckitt Benckiser Group PLC and German automobile maker Daimler AG.
Traders confronted a scarcity of catalysts in what was a relatively quiet day, with equity markets in the U.S. and China closed for holidays.
How markets are moving
The Stoxx Europe 600 index
On Friday, our Under the Radar Movers newsletter suggested small cap clinical-stage biopharmaceutical stock Bioline RX Ltd (NASDAQ: BLRX) as a speculative buy:
“Once again we’ve zoomed out to a long-term view of a stock we’re buying as it takes that view to see what’s really underway here. This is a major paradigm shift here, marked by the first higher low in months,....More>>>
A number of places have claimed to be the “next Silicon Valley.” While the one in California won’t go away, New York City, the research triangle in North Carolina and even Detroit say they will draw the best of tech talent due to special opportunities they can provide in the industry. The latest version of Silicon Valley will be in China, according to Ma Huateng, Tencent’s....More>>>
Growth stocks are a difficult breed, often requiring investors to venture into complicated and technically challenging sectors and niches. That is exactly the case with MongoDB (NASDAQ:MDB), a tech company that offers a database that can handle unstructured data. But our contributors have also made sure in this article to include a couple of names that don’t require a computer science degree....More>>>
&l;p&g;&l;img class=&q;dam-image ap size-large wp-image-6bd7458043cf44939ffccb0e61179029&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/6bd7458043cf44939ffccb0e61179029/960×0.jpg?fit=scale&q; data-height=&q;594&q; data-width=&q;960&q;&g; Made in China products are more expensive, and U.S. companies are still paying the price. Markets should get used to higher tariffs, and pick....More>>>
Verastem Inc. (NASDAQ: VSTM) shares saw a handy gain on Wednesday after the company set an exclusive licensing agreement with CSPC Pharmaceutical, a leading pharmaceutical company in China. The deal is to develop and commercialize Verastem’s Copiktra (duvelisib).
Copiktra previously received approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with....More>>>
Small cap robotics stock iRobot Corporation (NASDAQ: IRBT) reported Q2 2017 earnings after the market closed Tuesday with shares surging more than 21% in after hours trading. In a separate press release, iRobot Corporation announced that it has signed a definitive agreement to acquire privately-held Robopolis SAS (Robopolis), based in Lyon, France. This follows iRobot Corporation’s recent acquisition....More>>>
3 Things in the Markets to Know Right Now TheStreet’s May 5 “Investor Boot Camp” conference is coming up, and you won’t want to miss it. Quickly register here. Food for thought from Jefferies: The large-cap Russell 2000’s price-to-earnings multiple continues to contract and at 16.6 times, is off quite considerably versus the recent peak of 20 times. It....More>>>